Trial intelligence / Profile preview

JZP-258 versus placebo taste sameness study in healthy adults

NL-OMON46727Active, not recruiting

Sponsor
Jazz Pharmaceuticals plc
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in narcolepsy (2 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Ability to distinguish between JZP-258 and placebo for both replicates. Started Mar 2018; status: active, not recruiting.

02

Drugs

sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03

Conditions

narcolepsy

Beyond the preview

Go deeper on NL-OMON46727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON46727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call